• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Rare Periorbital Inflammation Reported After Subconjunctival Mitomycin C in Glaucoma Procedures

by
November 20, 2026
in Health
Reading Time: 2 mins read
0
Rare Periorbital Inflammation Reported After Subconjunctival Mitomycin C in Glaucoma Procedures

Rare Periorbital Inflammation Reported After Subconjunctival Mitomycin C in Glaucoma Procedures

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Two clinical cases have documented acute periorbital inflammation following the intended subconjunctival administration of mitomycin C during glaucoma filtering procedures. Mitomycin C is widely employed as an adjunctive antifibrotic agent in glaucoma filtration surgery and bleb revision. While ocular toxicity from the drug is well recognized, acute inflammatory responses involving the surrounding periorbital tissues remain rarely described in ophthalmic literature.

The first documented case involved a 36-year-old Thai woman diagnosed with juvenile open-angle glaucoma who underwent a trabeculectomy augmented with a subconjunctival mitomycin C injection at a dose of 20 micrograms in 0.1 milliliters. On the first postoperative day, the patient developed marked painful right upper eyelid edema, complete ptosis, chemosis, and pronounced limitation of extraocular movements.

Because an infectious etiology could not initially be excluded upon clinical presentation, clinicians initiated antimicrobial therapy in conjunction with corticosteroids. Following this intervention, clinical improvement was evident by the following day, progressing to complete resolution of symptoms and ocular signs within two weeks of presentation.

The second case report detailed a 62-year-old Thai man with primary open-angle glaucoma who underwent bleb needling supplemented with subconjunctival mitomycin C at a dose of 10 micrograms in 0.1 milliliters. Within five hours following the intervention, the patient developed left upper eyelid swelling and binocular diplopia.

Clinical evaluation subsequently revealed incomplete ptosis alongside marked limitation of medial gaze in the affected eye. The patient received treatment consisting of topical antimicrobial therapy paired with corticosteroids, leading to complete recovery of ocular motility and full resolution of the localized periorbital inflammation within three weeks.

Researchers observed that the short latency following mitomycin C exposure, coupled with the absence of convincing progressive infectious features, suggests a sterile toxic-inflammatory reaction. The clinical manifestations may be potentially related to the posterior anatomical spread of the antimetabolite within the orbit.

The authors noted that definitive causality cannot be established solely from these two isolated clinical presentations, emphasizing that active infection must always be considered during initial evaluation. Maintaining clinical awareness of this potential adverse event facilitates prompt diagnostic evaluation and appropriate therapeutic management following mitomycin C-augmented glaucoma interventions.

Subject of Research: Acute periorbital inflammation associated with subconjunctival mitomycin C in glaucoma surgery

Article Title: Acute periorbital inflammation following subconjunctival mitomycin C in trabeculectomy and bleb needling: two case reports

Article References: Euswas, S., Srisombut, T., Khomate, W., Kangwanwongpaisan, C., Supakontanasan, W., Petpiroon, P., & Suwan, Y. (2026). Acute periorbital inflammation following subconjunctival mitomycin C in trabeculectomy and bleb needling: two case reports. BMC Ophthalmology. https://doi.org/10.1186/s12886-026-05550-w

Image Credits: AI Generated

DOI: 10.1186/s12886-026-05550-w

Keywords: glaucoma filtration surgery, mitomycin C, trabeculectomy, bleb needling, periorbital inflammation, ocular toxicity, antifibrotic agents, ptosis, chemosis, diplopia, extraocular motility, ophthalmology, case report, corticosteroid therapy, sterile inflammation

News Source: Ophelia Keating. (November 20, 2026). Rare Periorbital Inflammation Reported After Subconjunctival Mitomycin C in Glaucoma Procedures. Scienmag.

Tags: antifibrotic agentsbleb needlingcase reportchemosiscorticosteroid therapydiplopiaextraocular motilityglaucoma filtration surgerymitomycin Cocular toxicityOphthalmologyperiorbital inflammationptosissterile inflammationtrabeculectomy
Share12Tweet7Share2ShareShareShare1

Related Posts

Endoscopic Bridge-Crane Technique Shows Technical Feasibility in Thoracic Spinal Ossification

Endoscopic Bridge-Crane Technique Shows Technical Feasibility in Thoracic Spinal Ossification

November 20, 2026
Radiologists Outperformed AI in Distinguishing COVID-19 From Other Viral Pneumonias on CT

Radiologists Outperformed AI in Distinguishing COVID-19 From Other Viral Pneumonias on CT

November 20, 2026

Streptococcus constellatus Lung Abscess and Fistula Identified in Severe Diabetic Ketoacidosis

November 20, 2026

Novel Orally Disintegrating Tablet Boosts Tegoprazan Bioavailability in Rat Study

November 20, 2026

POPULAR NEWS

  • Cardiovascular Review Examines Microplastics Evidence Across Human Tissues and Coronary Disease

    Cardiovascular Review Examines Microplastics Evidence Across Human Tissues and Coronary Disease

    29 shares
    Share 12 Tweet 7
  • New Estimand Framework Clarifies Model Validation and Data Splitting in Predictive Modelling

    29 shares
    Share 12 Tweet 7
  • Rare Periorbital Inflammation Reported After Subconjunctival Mitomycin C in Glaucoma Procedures

    29 shares
    Share 12 Tweet 7
  • Hands-On Workshops Sharply Increase Livestock Stakeholder Foot-And-Mouth Disease Recognition in Puerto Rico

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Seawater Immersion Weakens Thick Four Layer Carbon Fiber Cylinders More Than Thinner Tubes

Endoscopic Bridge-Crane Technique Shows Technical Feasibility in Thoracic Spinal Ossification

Open-Source Aletheia Pipeline Automates Quality-Control Dilution Filtering for Untargeted Metabolomics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.